RM3.90 不是Price Target, but is Trading buy.
First Price Target RM6.50.

Dnonce 还有排涨。

Fundamentals
The pandemic has created opportunities whereby manufacturers turn to automation to reduce their reliance on manpower in their manufacturing and production process as hiring foreign workers remains challenging during this period.

As a result, ISTONE has observed an increasing demand from manufacturers to automate their production capabilities which resulted in a surge in ISTONE's automation projects.

Also, ISTONE has appointed Dato’ Awang Daud bin Awang Putera as its new chairman and intends to leverage on the newly appointed chairman’s networking to venture into new industry such as oil and gas.

SCIB 是Industrial Product and Service Sector.
PER 最低是20x.
到了公布第二，第三，第四2020财年，SCIB's PER 自然会被调低的。

而且，合约陆续有来。

没错，是2年里，也就是在FY2020 & FY2021.
不是4年。

还记得HLT 集团在几个月前也proposed ESOS ,目的是要奖励员工们同时也为他们对公司一直以来的努力付出所作出的贡献。
现在的HLT 已经不是在penny stock 的状态了！
HLT 的ESOS 低于70 sen呢。
（你们可去查个究竟，bursa 网站有的）
ISTONE 这一支股没有这么快脱离penny stock condition的啦，慢慢地买卖吧！
相信在过不久大家可以看见Istone 会在50-60sen 之间交易买卖的。
Price Target RM1.00 要等它过了Fourth Quarter Report FY2020.
Istone 在MCO 期间都能记录取rm1,541,000盈利,第三及第四业绩盈利相信大家都心里有数了。一些在买卖着60 sen 的penny stocks是making loss of penny stocks, 可Istone 绝对不是！

红股计划我预料会在第四业绩出炉后宣布。

市值RM1.0 billion or 我们口头上说的RM10 亿，当作SCIB 值RM5亿好了。
目前，SCIB 市值才只有RM367.90 mil （即使我们只算RM3.00/share而已）
SCIB股数122.63 mil 张票。
市值RM5.0 亿意味着每一张票值RM4.08！

现在交易量已经达120 mil ，相信Istone可以突破200 mil 交易量今天。

Who is selling sure they are buying.back quickly just now.

SCIB 在获得rm300 mil 对就有RM2.0 bil contracts 在手里了，有排它忙碌了。FY2020 & FY2021 非常亮丽又靓丽。

上个星期五交易量破100 mil.
这个星期，也许看见交易量突破150 mil -200 mil了。
我已经买了Istone.
我Istone了，你们呢?

这里一些人发表的语言很无脑。
只能暗笑。

Opensys limit up today.
Both are technology stock.

https://www.thestar.com.my/news/nation/2020/08/20/pm-malaysia-must-master-technology

26 sen also eat eat eat.

我今天再加码了!

就是等他上位罢了。

DNONCE TECHNOLOGY Key Highlights
• Significant improvement in Profit Before Tax (“PBT”) from loss of RM3.34 million in 1H Year-to-date (“YTD”) 30 June 2019 to RM2.40 million, an increase of RM5.74 million or 172% for Financial Year Ended 30 April 2020 (“FYE 30 April 2020”).
• Noteworthy surge in revenue, average monthly sales for July 2019 till April 2020 was RM14.6 million compared with January 2019 till June 2019 of RM13.3 million representing a 9.8% increase, even though March and April sales were impacted by the Covid-19 induced MCO
• Three consecutive profitable quarters with FYE PBT of RM2.40 million signifying 9 straight months of profit until April since the new management took over the running of the Company.
D’nonce Technology Bhd (“D’nonce” or “the Group”) (“7114”), today announced its interim financial results for the sixth quarter (“Q6”) and 16-month consolidated financial results for its Financial Year Ended 30 April 2020 (“FYE 30 April 2020”).
DNONCE is a diversified engineering solutions provider, serving customers in the semiconductor, automotive, medical/healthcare, data storage hardware and consumer electronics industries with overseas subsidiaries in Thailand.
In mid-July 2019, D’nonce had installed a new Board of Directors and management, led by Mr. Tho Yow Yin as CEO. Under the new leadership.
DNONCE embarked on costcutting measures and redirected their focus to expand the Group’s growth in value-added businesses. These efforts have borne positive results as reflected in its financial performance since July 2019 to 30 April 2020.
D’nonce recorded a revenue of RM225 million for the FYE 30 April 2020, of which from 1 July 2019 to 30 April 2020, the Group recorded an average monthly revenue of RM14.6 million as compared to an average monthly revenue of RM13.3 million from 1 January 2019 to 30 June 2019, representing a 9.8% improvement in sales, despite the MCO which impacted operations in March and April 2020.
The significant increment of the revenue was partly contributed by the surge in demand from customers in the healthcare industry mainly due to the Covid-19 outbreak as D’nonce provides essential support to the glove industry in Southern Thailand and also supplies injection molded ventilator parts from their factory in Prai, Pulau Pinang.
Simultaneously, DNONCE continued to showcase a healthy and growing PBT having recorded a PBT of RM2.40 million for the Financial Period Ended 30 April 2020 reflecting a turnaround of RM5.74 million or 172% growth over the 1H Loss Before Tax of RM3.34 million. With the exception of Q6 FY2020 (which consisted of only 1 month), the Group achieved three consecutive quarters in the black (cumulative PBT of RM5.74 million from 1 July 2019 to 30 April 2020) - after losses earlier in the financial year throughout the first two quarters (cumulative Loss Before Tax of RM3.34 million from 1 January 2019 to 30 June 2019).

This is the result of the DNONCE Management’s continuous prudence in managing its expenses while expanding revenue, resulting in the highest level of operational efficiency and also the continuous growth of its business.
As of 30th April 2020 the Group has generated a positive cash flow of RM8.16 million from operating activities and have cash and bank balances of RM32.5 million. For the full FYE 30 April 2020, D’nonce recorded a Profit After Tax of RM0.73 million (after the non-cash adjustment from the revaluation of properties deficit of RM0.45 million) in spite of the net losses recorded for Financial Period Ended 30 June 2019.
Notwithstanding the challenging environment, DNONCE is cautiously optimistic of its business with the expectation of continued strong demand for its supplies to the medical and health sectors as well as the positive demand from the electronic technology sector moving forward.
DNONCE has active initiatives underway to enhance its overall organisational effectiveness.
These initiatives should increase productivity and cost efficiency while also helping to realise scale economies as Dnonce continues to grow its commercial opportunities.

两大利好围绕DNONCE！！
1）Provides Essential Support (Glove Industry) Southern Thailand

2） Injection Molded Ventilator Parts (Prai, Pulau Pinang)

预料，DNONCE 可突破RM1.00大关。

DNONCE TECHNOLOGY Key Highlights
• Significant improvement in Profit Before Tax (“PBT”) from loss of RM3.34 million in 1H Year-to-date (“YTD”) 30 June 2019 to RM2.40 million, an increase of RM5.74 million or 172% for Financial Year Ended 30 April 2020 (“FYE 30 April 2020”).
• Noteworthy surge in revenue, average monthly sales for July 2019 till April 2020 was RM14.6 million compared with January 2019 till June 2019 of RM13.3 million representing a 9.8% increase, even though March and April sales were impacted by the Covid-19 induced MCO
• Three consecutive profitable quarters with FYE PBT of RM2.40 million signifying 9 straight months of profit until April since the new management took over the running of the Company.
D’nonce Technology Bhd (“D’nonce” or “the Group”) (“7114”), today announced its interim financial results for the sixth quarter (“Q6”) and 16-month consolidated financial results for its Financial Year Ended 30 April 2020 (“FYE 30 April 2020”).
DNONCE is a diversified engineering solutions provider, serving customers in the semiconductor, automotive, medical/healthcare, data storage hardware and consumer electronics industries with overseas subsidiaries in Thailand.
In mid-July 2019, D’nonce had installed a new Board of Directors and management, led by Mr. Tho Yow Yin as CEO. Under the new leadership.
DNONCE embarked on costcutting measures and redirected their focus to expand the Group’s growth in value-added businesses. These efforts have borne positive results as reflected in its financial performance since July 2019 to 30 April 2020.
D’nonce recorded a revenue of RM225 million for the FYE 30 April 2020, of which from 1 July 2019 to 30 April 2020, the Group recorded an average monthly revenue of RM14.6 million as compared to an average monthly revenue of RM13.3 million from 1 January 2019 to 30 June 2019, representing a 9.8% improvement in sales, despite the MCO which impacted operations in March and April 2020.
The significant increment of the revenue was partly contributed by the surge in demand from customers in the healthcare industry mainly due to the Covid-19 outbreak as D’nonce provides essential support to the glove industry in Southern Thailand and also supplies injection molded ventilator parts from their factory in Prai, Pulau Pinang.
Simultaneously, DNONCE continued to showcase a healthy and growing PBT having recorded a PBT of RM2.40 million for the Financial Period Ended 30 April 2020 reflecting a turnaround of RM5.74 million or 172% growth over the 1H Loss Before Tax of RM3.34 million. With the exception of Q6 FY2020 (which consisted of only 1 month), the Group achieved three consecutive quarters in the black (cumulative PBT of RM5.74 million from 1 July 2019 to 30 April 2020) - after losses earlier in the financial year throughout the first two quarters (cumulative Loss Before Tax of RM3.34 million from 1 January 2019 to 30 June 2019).

This is the result of the DNONCE Management’s continuous prudence in managing its expenses while expanding revenue, resulting in the highest level of operational efficiency and also the continuous growth of its business.
As of 30th April 2020 the Group has generated a positive cash flow of RM8.16 million from operating activities and have cash and bank balances of RM32.5 million. For the full FYE 30 April 2020, D’nonce recorded a Profit After Tax of RM0.73 million (after the non-cash adjustment from the revaluation of properties deficit of RM0.45 million) in spite of the net losses recorded for Financial Period Ended 30 June 2019.
Notwithstanding the challenging environment, DNONCE is cautiously optimistic of its business with the expectation of continued strong demand for its supplies to the medical and health sectors as well as the positive demand from the electronic technology sector moving forward.
DNONCE has active initiatives underway to enhance its overall organisational effectiveness.
These initiatives should increase productivity and cost efficiency while also helping to realise scale economies as Dnonce continues to grow its commercial opportunities.

两大利好围绕DNONCE！！
1）Provides Essential Support (Glove Industry) Southern Thailand

2） Injection Molded Ventilator Parts (Prai, Pulau Pinang)

预料，DNONCE 可突破RM1.00大关。

DNONCE TECHNOLOGY Key Highlights
• Significant improvement in Profit Before Tax (“PBT”) from loss of RM3.34 million in 1H Year-to-date (“YTD”) 30 June 2019 to RM2.40 million, an increase of RM5.74 million or 172% for Financial Year Ended 30 April 2020 (“FYE 30 April 2020”).
• Noteworthy surge in revenue, average monthly sales for July 2019 till April 2020 was RM14.6 million compared with January 2019 till June 2019 of RM13.3 million representing a 9.8% increase, even though March and April sales were impacted by the Covid-19 induced MCO
• Three consecutive profitable quarters with FYE PBT of RM2.40 million signifying 9 straight months of profit until April since the new management took over the running of the Company.
D’nonce Technology Bhd (“D’nonce” or “the Group”) (“7114”), today announced its interim financial results for the sixth quarter (“Q6”) and 16-month consolidated financial results for its Financial Year Ended 30 April 2020 (“FYE 30 April 2020”).
DNONCE is a diversified engineering solutions provider, serving customers in the semiconductor, automotive, medical/healthcare, data storage hardware and consumer electronics industries with overseas subsidiaries in Thailand.
In mid-July 2019, D’nonce had installed a new Board of Directors and management, led by Mr. Tho Yow Yin as CEO. Under the new leadership.
DNONCE embarked on costcutting measures and redirected their focus to expand the Group’s growth in value-added businesses. These efforts have borne positive results as reflected in its financial performance since July 2019 to 30 April 2020.
D’nonce recorded a revenue of RM225 million for the FYE 30 April 2020, of which from 1 July 2019 to 30 April 2020, the Group recorded an average monthly revenue of RM14.6 million as compared to an average monthly revenue of RM13.3 million from 1 January 2019 to 30 June 2019, representing a 9.8% improvement in sales, despite the MCO which impacted operations in March and April 2020.
The significant increment of the revenue was partly contributed by the surge in demand from customers in the healthcare industry mainly due to the Covid-19 outbreak as D’nonce provides essential support to the glove industry in Southern Thailand and also supplies injection molded ventilator parts from their factory in Prai, Pulau Pinang.
Simultaneously, DNONCE continued to showcase a healthy and growing PBT having recorded a PBT of RM2.40 million for the Financial Period Ended 30 April 2020 reflecting a turnaround of RM5.74 million or 172% growth over the 1H Loss Before Tax of RM3.34 million. With the exception of Q6 FY2020 (which consisted of only 1 month), the Group achieved three consecutive quarters in the black (cumulative PBT of RM5.74 million from 1 July 2019 to 30 April 2020) - after losses earlier in the financial year throughout the first two quarters (cumulative Loss Before Tax of RM3.34 million from 1 January 2019 to 30 June 2019).

This is the result of the DNONCE Management’s continuous prudence in managing its expenses while expanding revenue, resulting in the highest level of operational efficiency and also the continuous growth of its business.
As of 30th April 2020 the Group has generated a positive cash flow of RM8.16 million from operating activities and have cash and bank balances of RM32.5 million. For the full FYE 30 April 2020, D’nonce recorded a Profit After Tax of RM0.73 million (after the non-cash adjustment from the revaluation of properties deficit of RM0.45 million) in spite of the net losses recorded for Financial Period Ended 30 June 2019.
Notwithstanding the challenging environment, DNONCE is cautiously optimistic of its business with the expectation of continued strong demand for its supplies to the medical and health sectors as well as the positive demand from the electronic technology sector moving forward.
DNONCE has active initiatives underway to enhance its overall organisational effectiveness.
These initiatives should increase productivity and cost efficiency while also helping to realise scale economies as Dnonce continues to grow its commercial opportunities.

两大利好围绕DNONCE！！
1）Provides Essential Support (Glove Industry) Southern Thailand

2） Injection Molded Ventilator Parts (Prai, Pulau Pinang)

预料，DNONCE 可突破RM1.00大关。

DNONCE TECHNOLOGY Key Highlights
• Significant improvement in Profit Before Tax (“PBT”) from loss of RM3.34 million in 1H Year-to-date (“YTD”) 30 June 2019 to RM2.40 million, an increase of RM5.74 million or 172% for Financial Year Ended 30 April 2020 (“FYE 30 April 2020”).
• Noteworthy surge in revenue, average monthly sales for July 2019 till April 2020 was RM14.6 million compared with January 2019 till June 2019 of RM13.3 million representing a 9.8% increase, even though March and April sales were impacted by the Covid-19 induced MCO
• Three consecutive profitable quarters with FYE PBT of RM2.40 million signifying 9 straight months of profit until April since the new management took over the running of the Company.
D’nonce Technology Bhd (“D’nonce” or “the Group”) (“7114”), today announced its interim financial results for the sixth quarter (“Q6”) and 16-month consolidated financial results for its Financial Year Ended 30 April 2020 (“FYE 30 April 2020”).
DNONCE is a diversified engineering solutions provider, serving customers in the semiconductor, automotive, medical/healthcare, data storage hardware and consumer electronics industries with overseas subsidiaries in Thailand.
In mid-July 2019, D’nonce had installed a new Board of Directors and management, led by Mr. Tho Yow Yin as CEO. Under the new leadership.
DNONCE embarked on costcutting measures and redirected their focus to expand the Group’s growth in value-added businesses. These efforts have borne positive results as reflected in its financial performance since July 2019 to 30 April 2020.
D’nonce recorded a revenue of RM225 million for the FYE 30 April 2020, of which from 1 July 2019 to 30 April 2020, the Group recorded an average monthly revenue of RM14.6 million as compared to an average monthly revenue of RM13.3 million from 1 January 2019 to 30 June 2019, representing a 9.8% improvement in sales, despite the MCO which impacted operations in March and April 2020.
The significant increment of the revenue was partly contributed by the surge in demand from customers in the healthcare industry mainly due to the Covid-19 outbreak as D’nonce provides essential support to the glove industry in Southern Thailand and also supplies injection molded ventilator parts from their factory in Prai, Pulau Pinang.
Simultaneously, DNONCE continued to showcase a healthy and growing PBT having recorded a PBT of RM2.40 million for the Financial Period Ended 30 April 2020 reflecting a turnaround of RM5.74 million or 172% growth over the 1H Loss Before Tax of RM3.34 million. With the exception of Q6 FY2020 (which consisted of only 1 month), the Group achieved three consecutive quarters in the black (cumulative PBT of RM5.74 million from 1 July 2019 to 30 April 2020) - after losses earlier in the financial year throughout the first two quarters (cumulative Loss Before Tax of RM3.34 million from 1 January 2019 to 30 June 2019).

This is the result of the DNONCE Management’s continuous prudence in managing its expenses while expanding revenue, resulting in the highest level of operational efficiency and also the continuous growth of its business.
As of 30th April 2020 the Group has generated a positive cash flow of RM8.16 million from operating activities and have cash and bank balances of RM32.5 million. For the full FYE 30 April 2020, D’nonce recorded a Profit After Tax of RM0.73 million (after the non-cash adjustment from the revaluation of properties deficit of RM0.45 million) in spite of the net losses recorded for Financial Period Ended 30 June 2019.
Notwithstanding the challenging environment, DNONCE is cautiously optimistic of its business with the expectation of continued strong demand for its supplies to the medical and health sectors as well as the positive demand from the electronic technology sector moving forward.
DNONCE has active initiatives underway to enhance its overall organisational effectiveness.
These initiatives should increase productivity and cost efficiency while also helping to realise scale economies as Dnonce continues to grow its commercial opportunities.

两大利好围绕DNONCE！！
1）Provides Essential Support (Glove Industry) Southern Thailand

2） Injection Molded Ventilator Parts (Prai, Pulau Pinang)

预料，DNONCE 可突破RM1.00大关。

DNONCE TECHNOLOGY Key Highlights
• Significant improvement in Profit Before Tax (“PBT”) from loss of RM3.34 million in 1H Year-to-date (“YTD”) 30 June 2019 to RM2.40 million, an increase of RM5.74 million or 172% for Financial Year Ended 30 April 2020 (“FYE 30 April 2020”).
• Noteworthy surge in revenue, average monthly sales for July 2019 till April 2020 was RM14.6 million compared with January 2019 till June 2019 of RM13.3 million representing a 9.8% increase, even though March and April sales were impacted by the Covid-19 induced MCO
• Three consecutive profitable quarters with FYE PBT of RM2.40 million signifying 9 straight months of profit until April since the new management took over the running of the Company.
D’nonce Technology Bhd (“D’nonce” or “the Group”) (“7114”), today announced its interim financial results for the sixth quarter (“Q6”) and 16-month consolidated financial results for its Financial Year Ended 30 April 2020 (“FYE 30 April 2020”).
DNONCE is a diversified engineering solutions provider, serving customers in the semiconductor, automotive, medical/healthcare, data storage hardware and consumer electronics industries with overseas subsidiaries in Thailand.
In mid-July 2019, D’nonce had installed a new Board of Directors and management, led by Mr. Tho Yow Yin as CEO. Under the new leadership.
DNONCE embarked on costcutting measures and redirected their focus to expand the Group’s growth in value-added businesses. These efforts have borne positive results as reflected in its financial performance since July 2019 to 30 April 2020.
D’nonce recorded a revenue of RM225 million for the FYE 30 April 2020, of which from 1 July 2019 to 30 April 2020, the Group recorded an average monthly revenue of RM14.6 million as compared to an average monthly revenue of RM13.3 million from 1 January 2019 to 30 June 2019, representing a 9.8% improvement in sales, despite the MCO which impacted operations in March and April 2020.
The significant increment of the revenue was partly contributed by the surge in demand from customers in the healthcare industry mainly due to the Covid-19 outbreak as D’nonce provides essential support to the glove industry in Southern Thailand and also supplies injection molded ventilator parts from their factory in Prai, Pulau Pinang.
Simultaneously, DNONCE continued to showcase a healthy and growing PBT having recorded a PBT of RM2.40 million for the Financial Period Ended 30 April 2020 reflecting a turnaround of RM5.74 million or 172% growth over the 1H Loss Before Tax of RM3.34 million. With the exception of Q6 FY2020 (which consisted of only 1 month), the Group achieved three consecutive quarters in the black (cumulative PBT of RM5.74 million from 1 July 2019 to 30 April 2020) - after losses earlier in the financial year throughout the first two quarters (cumulative Loss Before Tax of RM3.34 million from 1 January 2019 to 30 June 2019).

This is the result of the DNONCE Management’s continuous prudence in managing its expenses while expanding revenue, resulting in the highest level of operational efficiency and also the continuous growth of its business.
As of 30th April 2020 the Group has generated a positive cash flow of RM8.16 million from operating activities and have cash and bank balances of RM32.5 million. For the full FYE 30 April 2020, D’nonce recorded a Profit After Tax of RM0.73 million (after the non-cash adjustment from the revaluation of properties deficit of RM0.45 million) in spite of the net losses recorded for Financial Period Ended 30 June 2019.
Notwithstanding the challenging environment, DNONCE is cautiously optimistic of its business with the expectation of continued strong demand for its supplies to the medical and health sectors as well as the positive demand from the electronic technology sector moving forward.
DNONCE has active initiatives underway to enhance its overall organisational effectiveness.
These initiatives should increase productivity and cost efficiency while also helping to realise scale economies as Dnonce continues to grow its commercial opportunities.

两大利好围绕DNONCE！！
1）Provides Essential Support (Glove Industry) Southern Thailand

2） Injection Molded Ventilator Parts (Prai, Pulau Pinang)

预料，DNONCE 可突破RM1.00大关。

DNONCE TECHNOLOGY Key Highlights
• Significant improvement in Profit Before Tax (“PBT”) from loss of RM3.34 million in 1H Year-to-date (“YTD”) 30 June 2019 to RM2.40 million, an increase of RM5.74 million or 172% for Financial Year Ended 30 April 2020 (“FYE 30 April 2020”).
• Noteworthy surge in revenue, average monthly sales for July 2019 till April 2020 was RM14.6 million compared with January 2019 till June 2019 of RM13.3 million representing a 9.8% increase, even though March and April sales were impacted by the Covid-19 induced MCO
• Three consecutive profitable quarters with FYE PBT of RM2.40 million signifying 9 straight months of profit until April since the new management took over the running of the Company.
D’nonce Technology Bhd (“D’nonce” or “the Group”) (“7114”), today announced its interim financial results for the sixth quarter (“Q6”) and 16-month consolidated financial results for its Financial Year Ended 30 April 2020 (“FYE 30 April 2020”).
DNONCE is a diversified engineering solutions provider, serving customers in the semiconductor, automotive, medical/healthcare, data storage hardware and consumer electronics industries with overseas subsidiaries in Thailand.
In mid-July 2019, D’nonce had installed a new Board of Directors and management, led by Mr. Tho Yow Yin as CEO. Under the new leadership.
DNONCE embarked on costcutting measures and redirected their focus to expand the Group’s growth in value-added businesses. These efforts have borne positive results as reflected in its financial performance since July 2019 to 30 April 2020.
D’nonce recorded a revenue of RM225 million for the FYE 30 April 2020, of which from 1 July 2019 to 30 April 2020, the Group recorded an average monthly revenue of RM14.6 million as compared to an average monthly revenue of RM13.3 million from 1 January 2019 to 30 June 2019, representing a 9.8% improvement in sales, despite the MCO which impacted operations in March and April 2020.
The significant increment of the revenue was partly contributed by the surge in demand from customers in the healthcare industry mainly due to the Covid-19 outbreak as D’nonce provides essential support to the glove industry in Southern Thailand and also supplies injection molded ventilator parts from their factory in Prai, Pulau Pinang.
Simultaneously, DNONCE continued to showcase a healthy and growing PBT having recorded a PBT of RM2.40 million for the Financial Period Ended 30 April 2020 reflecting a turnaround of RM5.74 million or 172% growth over the 1H Loss Before Tax of RM3.34 million. With the exception of Q6 FY2020 (which consisted of only 1 month), the Group achieved three consecutive quarters in the black (cumulative PBT of RM5.74 million from 1 July 2019 to 30 April 2020) - after losses earlier in the financial year throughout the first two quarters (cumulative Loss Before Tax of RM3.34 million from 1 January 2019 to 30 June 2019).

This is the result of the DNONCE Management’s continuous prudence in managing its expenses while expanding revenue, resulting in the highest level of operational efficiency and also the continuous growth of its business.
As of 30th April 2020 the Group has generated a positive cash flow of RM8.16 million from operating activities and have cash and bank balances of RM32.5 million. For the full FYE 30 April 2020, D’nonce recorded a Profit After Tax of RM0.73 million (after the non-cash adjustment from the revaluation of properties deficit of RM0.45 million) in spite of the net losses recorded for Financial Period Ended 30 June 2019.
Notwithstanding the challenging environment, DNONCE is cautiously optimistic of its business with the expectation of continued strong demand for its supplies to the medical and health sectors as well as the positive demand from the electronic technology sector moving forward.
DNONCE has active initiatives underway to enhance its overall organisational effectiveness.
These initiatives should increase productivity and cost efficiency while also helping to realise scale economies as Dnonce continues to grow its commercial opportunities.

两大利好围绕DNONCE！！
1）Provides Essential Support (Glove Industry) Southern Thailand

2） Injection Molded Ventilator Parts (Prai, Pulau Pinang)

预料，DNONCE 可突破RM1.00大关。

DNONCE TECHNOLOGY Key Highlights
• Significant improvement in Profit Before Tax (“PBT”) from loss of RM3.34 million in 1H Year-to-date (“YTD”) 30 June 2019 to RM2.40 million, an increase of RM5.74 million or 172% for Financial Year Ended 30 April 2020 (“FYE 30 April 2020”).
• Noteworthy surge in revenue, average monthly sales for July 2019 till April 2020 was RM14.6 million compared with January 2019 till June 2019 of RM13.3 million representing a 9.8% increase, even though March and April sales were impacted by the Covid-19 induced MCO
• Three consecutive profitable quarters with FYE PBT of RM2.40 million signifying 9 straight months of profit until April since the new management took over the running of the Company.
D’nonce Technology Bhd (“D’nonce” or “the Group”) (“7114”), today announced its interim financial results for the sixth quarter (“Q6”) and 16-month consolidated financial results for its Financial Year Ended 30 April 2020 (“FYE 30 April 2020”).
DNONCE is a diversified engineering solutions provider, serving customers in the semiconductor, automotive, medical/healthcare, data storage hardware and consumer electronics industries with overseas subsidiaries in Thailand.
In mid-July 2019, D’nonce had installed a new Board of Directors and management, led by Mr. Tho Yow Yin as CEO. Under the new leadership.
DNONCE embarked on costcutting measures and redirected their focus to expand the Group’s growth in value-added businesses. These efforts have borne positive results as reflected in its financial performance since July 2019 to 30 April 2020.
D’nonce recorded a revenue of RM225 million for the FYE 30 April 2020, of which from 1 July 2019 to 30 April 2020, the Group recorded an average monthly revenue of RM14.6 million as compared to an average monthly revenue of RM13.3 million from 1 January 2019 to 30 June 2019, representing a 9.8% improvement in sales, despite the MCO which impacted operations in March and April 2020.
The significant increment of the revenue was partly contributed by the surge in demand from customers in the healthcare industry mainly due to the Covid-19 outbreak as D’nonce provides essential support to the glove industry in Southern Thailand and also supplies injection molded ventilator parts from their factory in Prai, Pulau Pinang.
Simultaneously, DNONCE continued to showcase a healthy and growing PBT having recorded a PBT of RM2.40 million for the Financial Period Ended 30 April 2020 reflecting a turnaround of RM5.74 million or 172% growth over the 1H Loss Before Tax of RM3.34 million. With the exception of Q6 FY2020 (which consisted of only 1 month), the Group achieved three consecutive quarters in the black (cumulative PBT of RM5.74 million from 1 July 2019 to 30 April 2020) - after losses earlier in the financial year throughout the first two quarters (cumulative Loss Before Tax of RM3.34 million from 1 January 2019 to 30 June 2019).

This is the result of the DNONCE Management’s continuous prudence in managing its expenses while expanding revenue, resulting in the highest level of operational efficiency and also the continuous growth of its business.
As of 30th April 2020 the Group has generated a positive cash flow of RM8.16 million from operating activities and have cash and bank balances of RM32.5 million. For the full FYE 30 April 2020, D’nonce recorded a Profit After Tax of RM0.73 million (after the non-cash adjustment from the revaluation of properties deficit of RM0.45 million) in spite of the net losses recorded for Financial Period Ended 30 June 2019.
Notwithstanding the challenging environment, DNONCE is cautiously optimistic of its business with the expectation of continued strong demand for its supplies to the medical and health sectors as well as the positive demand from the electronic technology sector moving forward.
DNONCE has active initiatives underway to enhance its overall organisational effectiveness.
These initiatives should increase productivity and cost efficiency while also helping to realise scale economies as Dnonce continues to grow its commercial opportunities.

两大利好围绕DNONCE！！
1）Provides Essential Support (Glove Industry) Southern Thailand

2） Injection Molded Ventilator Parts (Prai, Pulau Pinang)

预料，DNONCE 可突破RM1.00大关。

DNONCE TECHNOLOGY Key Highlights
• Significant improvement in Profit Before Tax (“PBT”) from loss of RM3.34 million in 1H Year-to-date (“YTD”) 30 June 2019 to RM2.40 million, an increase of RM5.74 million or 172% for Financial Year Ended 30 April 2020 (“FYE 30 April 2020”).
• Noteworthy surge in revenue, average monthly sales for July 2019 till April 2020 was RM14.6 million compared with January 2019 till June 2019 of RM13.3 million representing a 9.8% increase, even though March and April sales were impacted by the Covid-19 induced MCO
• Three consecutive profitable quarters with FYE PBT of RM2.40 million signifying 9 straight months of profit until April since the new management took over the running of the Company.
D’nonce Technology Bhd (“D’nonce” or “the Group”) (“7114”), today announced its interim financial results for the sixth quarter (“Q6”) and 16-month consolidated financial results for its Financial Year Ended 30 April 2020 (“FYE 30 April 2020”).
DNONCE is a diversified engineering solutions provider, serving customers in the semiconductor, automotive, medical/healthcare, data storage hardware and consumer electronics industries with overseas subsidiaries in Thailand.
In mid-July 2019, D’nonce had installed a new Board of Directors and management, led by Mr. Tho Yow Yin as CEO. Under the new leadership.
DNONCE embarked on costcutting measures and redirected their focus to expand the Group’s growth in value-added businesses. These efforts have borne positive results as reflected in its financial performance since July 2019 to 30 April 2020.
D’nonce recorded a revenue of RM225 million for the FYE 30 April 2020, of which from 1 July 2019 to 30 April 2020, the Group recorded an average monthly revenue of RM14.6 million as compared to an average monthly revenue of RM13.3 million from 1 January 2019 to 30 June 2019, representing a 9.8% improvement in sales, despite the MCO which impacted operations in March and April 2020.
The significant increment of the revenue was partly contributed by the surge in demand from customers in the healthcare industry mainly due to the Covid-19 outbreak as D’nonce provides essential support to the glove industry in Southern Thailand and also supplies injection molded ventilator parts from their factory in Prai, Pulau Pinang.
Simultaneously, DNONCE continued to showcase a healthy and growing PBT having recorded a PBT of RM2.40 million for the Financial Period Ended 30 April 2020 reflecting a turnaround of RM5.74 million or 172% growth over the 1H Loss Before Tax of RM3.34 million. With the exception of Q6 FY2020 (which consisted of only 1 month), the Group achieved three consecutive quarters in the black (cumulative PBT of RM5.74 million from 1 July 2019 to 30 April 2020) - after losses earlier in the financial year throughout the first two quarters (cumulative Loss Before Tax of RM3.34 million from 1 January 2019 to 30 June 2019).

This is the result of the DNONCE Management’s continuous prudence in managing its expenses while expanding revenue, resulting in the highest level of operational efficiency and also the continuous growth of its business.
As of 30th April 2020 the Group has generated a positive cash flow of RM8.16 million from operating activities and have cash and bank balances of RM32.5 million. For the full FYE 30 April 2020, D’nonce recorded a Profit After Tax of RM0.73 million (after the non-cash adjustment from the revaluation of properties deficit of RM0.45 million) in spite of the net losses recorded for Financial Period Ended 30 June 2019.
Notwithstanding the challenging environment, DNONCE is cautiously optimistic of its business with the expectation of continued strong demand for its supplies to the medical and health sectors as well as the positive demand from the electronic technology sector moving forward.
DNONCE has active initiatives underway to enhance its overall organisational effectiveness.
These initiatives should increase productivity and cost efficiency while also helping to realise scale economies as Dnonce continues to grow its commercial opportunities.

两大利好围绕DNONCE！！
1）Provides Essential Support (Glove Industry) Southern Thailand

2） Injection Molded Ventilator Parts (Prai, Pulau Pinang)

预料，DNONCE 可突破RM1.00大关。

5G coming.....
GPacket terbang, next will be KUB?

Currently, is it Dato Awang Dauh is major shareholder of ISTONE?

It will add the profit of selling estates.

疫苗新闻越来越多了。

https://www.orientaldaily.com.my/news/international/2020/08/10/356846

https://www.orientaldaily.com.my/news/international/2020/08/10/356846

Investors loss patient and worry about vaccine news day by day.

买卖vol很少。

CAREPLS最新业绩 显示，告诉大家。

Cash and bank balances RM17,185,000 （同期才有RM5,697,000而已）

Operating profit before working capital changes RM35,537,000 (同期才有RM22,005,000而已)

Net cash from/(used in) financing activities RM11,004,000 （同期是负RM31,749,000)

Cash and cash equivalents comprise RM26,665,000 (同期才有RM6,118,000 而已）
下一个业绩出炉了，PE 自然会调低的。

The next QR is FY2020 third quarter report going to compare with FY2019 third quarter report with -RM4,936,000.

Carepls随便记录RM20 mil-30 mil （没去计算生产线的话） for its third quarter report Fy3020, 都大大刺激买卖活动了到那个时候，更何况Carepls 还在努力着增加生产线为了应付手套需求呢至6 billion 多手套呢。
至明年尾看上8 billion 多。
上个星期五才宣布又忽然购入工厂增加多15条生产线呢！

https://klse.i3investor.com/blogs/freetospeak/2020-08-08-story-h1511613432-Supermax_OBM_The_George_Soros_bet.jsp

https://klse.i3investor.com/blogs/freetospeak/2020-08-08-story-h1511613432-Supermax_OBM_The_George_Soros_bet.jsp

大家一定要阅读以上的资讯！

http://news.seehua.com/?p=589003&fbclid=IwAR0k0_p-9f4_QwYPlpr2gQzNszq3FgU7UlatDq9Kigdvsi28WfCT-TMVVBI

交易量已经是110 mil了，到了下午，会更加大。tomei, Nice, pohkong hit almost limit up level and LIMIT UP already.

I added.

今天Carepls LIMIT UP 的话，我们大家就在RM6.65/6.66 见面。

SUPERMAX 公布的业绩会是进步的净利表现。

总会有人妒忌他人当那条水错过和买不到的股。

Net earning per annum not only RM87.92 mil

Me too, accumulate Carepls.

Iif take counting ASP increase price , CAREPLS NET EARNING WILL BE MORE THAN RM1.00 BILLION PER ANNUM.

Good blog, well calculate of Supermax.
Goldberg.

Bro, Harris.
在这未来的12-18 months里，ASP 会持续增加因不能完全fulfill 全世界（190个多国家）对手套的需求。就算是那个人现在订购手套，都要等很久很久才可能拿到货（等整一年左右）